Interleukin-33 Triggers B1 Cell Expansion and Its Release of Monocyte/Macrophage Chemoattractants and Growth Factors

Scandinavian Journal of Immunology

Volumn 82, Issue 2, 2015, Pages 118-124

  Ahmed, Ammad ^a   Koma, Mousa Komai ^a  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 33; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; CCL2 PROTEIN, MOUSE; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-33, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B1B CELL; BODY WEIGHT; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRANULOCYTE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WEIGHT GAIN; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MACROPHAGE; SECRETION (PROCESS);

ANIMALS; B-LYMPHOCYTE SUBSETS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84936091859     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12312     Document Type: Article

References (32)

1. Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001;13:195-201.
2. Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007;7:213-9.
3. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
4. Fagarasan S, Watanabe N, Honjo T. Generation, expansion, migration and activation of mouse B1 cells. Immunol Rev 2000;176:205-15.
5. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005;23:7-18.
6. Leong JM, Woodland RT, Muramatsu M, Honjo T. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 2004;21:379-90.
7. Kopf M, Brombacher F, Hodgkin PD et al. IL-5-deficient mice have a developmental defect in CD5 + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996;4:15-24.
8. Nisitani S, Sakiyama T, Honjo T. Involvement of IL-10 in induction of autoimmune hemolytic anemia in anti-erythrocyte Ig transgenic mice. Int Immunol 1998;10:1039-47.
9. Vink A, Warnier G, Brombacher F. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 1999;189:1413-23.
10. Komai-Koma M, Gilchrist DS, McKenzie ANJ, Goodyear CS, Xu D, Liew FY. IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol 2011;186:2584-91.
11. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
12. Cayrol C, Girard J-P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009;106:9021-6.
13. Lüthi AU, Cullen SP, McNeela EA et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009;31:84-98.
14. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007;179:2551-5.
15. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007;104:18660-5.
16. Kurowska-Stolarska M, Stolarski B, Kewin P et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009;183:6469-77.
17. Mayuzumi N, Matsushima H, Takashima A. IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur J Immunol 2009;39:3331-42.
18. Zaiss MM, Kurowska-Stolarska M, Böhm C et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J Immunol 2011;186:6097-105.
19. Shaik-Dasthagirisaheb YB, Varvara G, Murmura G et al. Vascular endothelial growth factor (VEGF), mast cells and inflammation. Int J Immunopathol Pharmacol 2013;26:327-35.
20. Miller AM, Xu D, Asquith DL, Denby L, Li Y. IL-33 reduces the development of atherosclerosis. J Exp Med 2008;205:339-46.
21. Xu D, Jiang H-R, Kewin P et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008;105:10913-8.
22. Brint EK, Xu D, Liu H, Dunne A, McKenzie A. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature 2004;5:373-9.
23. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000;191:1069-76.
24. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999;72:7-29.
25. Yoshimura T, Howard O, Ito T. Monocyte chemoattractant protein-1. CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One 2013;8:e58791.
26. Maurer M, Stebut Von E. Macrophage inflammatory protein-1. Int J Biochem Cell 2004;36(10):1882-6.
27. Ren M, Guo Q, Guo L, Lenz M, Qian F. Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO 2010;29:3952-66.
28. Metcalf D. The molecular control of cell division, differentiation commit-ment and maturation in haemopoietic cells. Nature 1989;339:27-30.
29. Francisco-Cruz A, Aguilar-Santelises M, Ramos-Espinosa O et al. Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor. Med Oncol 2014;31:774.
30. Weisbart RH, Kwan L, Golde DW. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 1987;69:18-21.
31. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986;67:257-67.
32. Llop-Guevara A, Chu DK, Walker TD, Goncharova S. A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure. PLoS One 2014;14:e88714.